Authors: | LaFemina, J.; Brennan, M. F. |
Article Title: | Adrenocortical carcinoma: Past, present, and future |
Abstract: | Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Due to its rarity, heterogeneity, and a lack of a comprehensive understanding of the pathogenesis, little progress has been made in treatment and outcomes. The current review explores the past, present, and future of the understanding and treatment of this disease process. © 2012 Wiley Periodicals, Inc. |
Keywords: | treatment outcome; cancer surgery; overall survival; clinical feature; disease course; pathogenesis; review; cisplatin; doxorubicin; artificial embolism; diarrhea; disease classification; drug dose reduction; disease free survival; cancer staging; neurotoxicity; outcome assessment; cancer diagnosis; metastasis; anemia; etoposide; nausea; vomiting; weight reduction; steroid; adrenal cortex carcinoma; fever; cancer invasion; liver metastasis; lung metastasis; cancer size; hydrocortisone; management; outcomes; mitotane; adrenocortical carcinoma; 17 oxosteroid; adrenal cortex neoplasms; streptozocin; fludrocortisone; adrenalectomy; cushing syndrome; metastasis resection; virilization; feminization |
Journal Title: | Journal of Surgical Oncology |
Volume: | 106 |
Issue: | 5 |
ISSN: | 0022-4790 |
Publisher: | Wiley Blackwell |
Date Published: | 2012-10-01 |
Start Page: | 586 |
End Page: | 594 |
Language: | English |
DOI: | 10.1002/jso.23112 |
PROVIDER: | scopus |
PUBMED: | 22473597 |
DOI/URL: | |
Notes: | --- - "Export Date: 1 October 2012" - "CODEN: JSONA" - "Source: Scopus" |